CLEC3B and liver cancer: In addition, another study found that downregulation of exosome-derived CLEC3B can promote liver cancer metastasis, EMT, and angiogenesis through the AMPK and VEGF signaling pathways, and suggested that CLEC3B in exosomes may be a new prognostic factor and a potential therapeutic target for liver cancer (50).